Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Seborrheic dermatitis was most common in late adults and toddlers from 2016 to 2019.

Antioxidant-rich maize varieties can improve health and need local support for widespread farming.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

The nanoemulsions effectively promoted hair growth in male rats.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Knuckle darkening can be an early sign of vitamin B12 deficiency.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

The brothers have congenital ichthyosis, and the older brother's eye issues are due to different genetic mutations.

There is a significant relationship between androgenic alopecia, hypertension, and diabetes mellitus.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

Keratin proteins in epithelial cells are dynamic and crucial for cell processes and disease understanding.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

Dkk4 protein is necessary for the proper development and arrangement of hair follicles.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

The document explains how to make antibacterial microneedles inspired by lamprey teeth to help heal infected wounds.